Goldman-backed biotech firm Ascletis becomes first to apply for HK IPO under new rules

Goldman-backed biotech firm Ascletis becomes first to apply for HK IPO under new rules

Ascletis Pharma

AscletisHKEx

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.